In Pfizer's (PFE) second quarter results, the pharmaceutical giant reported revenue and earnings above expectations while lifting full-year outlook. Merck (MRK) has also topped estimates, raising its full-year sales guidance, but trimming its adjusted profit guidance.

Morning Brief hosts Brad Smith and Seana Smith discuss catalysts for the companies, from cancer therapies to new product pipelines.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This article was written by Gabriel Roy